Literature DB >> 26165227

Why not the GP? Client preferences for sexually transmissible infection testing in Western Sydney.

Karen Biggs1, Jennifer Walsh1.   

Abstract

UNLABELLED: Background Publicly funded sexual health services (PFSHS) in NSW use triage to prioritise access for people at increased risk of infection and refer people at lower risk to General Practitioners (GPs). This study aimed to determine why people in Western Sydney attend a PFSHS in preference to their GP, whether they would be willing to see their GP for sexual health services and what factors were important when making this decision.
METHODS: An anonymous self-administered questionnaire was used for this study.
RESULTS: In total, 228/249 (92%) of all respondents had visited a GP in the previous 12 months; 192/249 (77%) knew the GP could perform sexually transmissible infection testing (STI) testing; 124/249 (50%) had ever had a STI check with a GP and 101/249 (41%) were willing to attend a GP service for STI-related care in the future. Factors relating to the health service staff and client comfort emerged as strong reasons for choice of health service. One-third of non-priority clients (33%) were unwilling to see a GP for STI testing in the future. Respondents raised concerns regarding perceived issues with confidentiality and lack of confidence in the GP's expertise in sexual health.
CONCLUSIONS: The underlying factors relating to sexual health care with the GP, whether real or perceived, need to be addressed in order for PFSHS to successfully triage out attendees who are at a lower STI risk.

Entities:  

Year:  2015        PMID: 26165227     DOI: 10.1071/SH15073

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  1 in total

1.  Distance as explanatory factor for sexual health centre utilization: an urban population-based study in the Netherlands.

Authors:  Denise E Twisk; Bram Meima; Daan Nieboer; Jan Hendrik Richardus; Hannelore M Götz
Journal:  Eur J Public Health       Date:  2021-12-01       Impact factor: 3.367

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.